Atlas Trials

An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

Clinical trial NCT00374166 · COMPLETED

Trial details

NCT number
NCT00374166
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anxiety Disorders
Start date
2006-08-01
Primary completion
2008-02-01
Enrollment
325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.